ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Efficacy"

  • 2022 American Transplant Congress

    Real-Life Prevention of Breakthrough SARS-CoV-2 Infections by mRNA Vaccines in Kidney Transplant Recipients vs Hemodialysis Patients

    D. Rodríguez-Espinosa, E. Montagud-Marrahi, J. Cacho, C. Arana, N. Taurizano, E. Hermida, J. Del Risco, J. Casals, A. Rosario, E. Cuadrado, N. Rodríguez, I. Revuelta, B. Bayès, P. Ventura-Aguiar, F. Cofan, E. Poch, F. Oppenheimer, M. Vera, L. Rodas, F. Maduell, F. Diekmann, A. Cases, J. Broseta, D. Cucchiari

    Nephrology and Renal Transplantation, Hospital Clinic of Barcelona, Barcelona, Spain

    *Purpose: The increased COVID-19 severity observed in kidney transplant recipients (KTR) has been widely reported. In addition, several studies have shown a reduced humoral and…
  • 2022 American Transplant Congress

    Efficacy and Safety of Denosumab on Osteoporosis in Kidney Transplant Recipients

    W. Park, J. Kwon, J. Lim, Y. Kim, J. Paek, K. Jin, S. Han

    Division of Nephrology, Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of

    *Purpose: The use of immunosuppressive agents, especially glucocorticoids, are associated with increased risks of bone loss in kidney transplant recipients (KTRs). Denosumab, a potent antiresorptive…
  • 2022 American Transplant Congress

    Safety and Efficacy of Peri-Vaccination Antimetabolite Hold to Augment Third SARS-CoV-2 Vaccine Dose Response in Lung Transplant Recipients

    S. Frey, J. Ruck, J. Alejo, L. Barker, W. Werbel, R. Avery, D. Segev, P. Shah

    Johns Hopkins University School of Medicine, Baltimore, MD

    *Purpose: Lung transplant recipients (LTRs) are less likely than other solid organ transplant recipients (SOTRs) to develop an antibody response to SARS-CoV-2 vaccination. Mycophenolate has…
  • 2022 American Transplant Congress

    Poor Tolerability of CFTR Modulator Therapy in Lung Transplant Recipients

    C. Doligalski, C. McKinzie, A. Yang, R. Coakley

    UNC Health, Chapel Hill, NC

    *Purpose: Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) is a highly effective therapy for cystic fibrosis (CF) with potential benefits in lung transplant recipients (LTRs) for extrapulmonary CF manifestations, however…
  • 2022 American Transplant Congress

    Evaluation of Conversion from Immediate Release (IR) Tacrolimus to LCP-Tacrolimus (Envarsus XR®, LCP) in Heart Transplant Recipients

    E. Foster1, A. Iaria1, J. Negrelli2, M. Fine2, M. Yu2, M. Liebo2

    1University of Illinois at Chicago, Chicago, IL, 2Loyola University Medical Center, Maywood, IL

    *Purpose: The purpose of this study was to assess outcomes in heart transplant recipients who were converted from IR tacrolimus to LCPT. Limited data exists…
  • 2022 American Transplant Congress

    Noroviral Diarrhea in Solid Organ Transplant Recipients: Characteristics, Interventions and Outcomes

    S. N. Nair, A. Bhaskaran, A. Chandorkar, L. Fontana, K. Obeid

    University of Minnesota, Minneapolis, MN

    *Purpose: Norovirus may result in significant morbidity in solid organ transplant (SOT) recipients. There is limited evidence for therapeutics beyond supportive care for the management…
  • 2022 American Transplant Congress

    Enhanced Delivery of Nanomedicine to Human Kidney During Ex Vivo Perfusion

    C. Albert1, L. Bracaglia1, A. Koide2, J. R. DiRito1, T. Lysyy1, E. Christopher1, J. Grundler1, J. T. Langford1, D. Haakinson1, J. S. Pober1, W. M. Saltzman1, S. Koide2, G. Tietjen1

    1Yale University, new haven, CT, 2Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY

    *Purpose: An efficient delivery of therapeutic agents to graft endothelial cells (ECs) prior to transplantation could render organs more resistant to injury, improving clinical outcomes…
  • 2022 American Transplant Congress

    Complement 5 Regulation Ameliorates Antibody-Mediated Rejection After Liver Transplantation in Rats

    T. Tajima1, K. Hata1, J. Kusakabe1, H. Miyauchi1, X. Zhao1, S. Kageyama1, T. Okamoto1, Y. Wang2, E. Hatano1

    1Dept. of HBP Surgery & Transplantation, Kyoto University, Kyoto, Japan, 2Alexion Pharmaceuticals Inc., New Haven, CT

    *Purpose: Antibody-mediated rejection (AMR) is a refractory rejection after donor-specific antibody (DSA)-positive or blood-type incompatible organ transplantation. Since AMR significantly deteriorates transplant outcomes, there is…
  • 2022 American Transplant Congress

    Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on Covid-19 Infection in Kidney Transplant Recipients

    N. Sutharattanapong, S. Thotsiri, S. Kantachuvesiri, P. Wiwattanathum

    Excellent Center of Organ Transplantation, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    *Purpose: Most developing countries do not have access to high-efficiency mRNA vaccine. In Thailand, the first and most available vaccines were inactivated, and later on,…
  • 2022 American Transplant Congress

    External Validation of the Abbreviated Ibox Scoring System at One-Year Post Kidney Transplant as a Surrogate Endpoint for Death-Censored Graft Survival

    A. Klein1, L. Kosinski2, R. Muse2, A. Loupy3, O. Aubert3, G. Divard3, M. Stegall4, I. Helanterä5, W. E. Fitzsimmons1, I. O'Doherty1

    1Transplant Therapeutics Consortium, Critical Path Institute, Tucson, AZ, 2Critical Path Institute, Tucson, AZ, 3Paris Transplant Group, Paris, France, 4Mayo Clinic, Rochester, MN, 5Helsinki University Hospital, Helsinki, Finland

    *Purpose: The Transplant Therapeutics Consortium seeks to translate the iBox from Loupy et al., 2019 into a surrogate endpoint for five-year death-censored graft survival after…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences